Gilead Sciences, Inc.

GILDNASDAQHealthcare● Active

$129.27

+$0.11(+0.08%)

Market Cap$160.5B

P/E Ratio—

52W High$157.29

52W Low$104.46

Avg Volume6.1M

Open$130.07

Beta0.33

Overview

Gilead Sciences, Inc. (GILD) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

GILD · net income · updated Jun 8, 2026

Core profitability metrics

GILD · net income · margin · TTM · CAGR

Net income was $8.51B for FY2025 (fiscal year ending 2025-12-31), up 1672.9% year-over-year. Net profit margin was 28.9%. Based on available data, Gilead Sciences, Inc. has been profitable since at least 2011.

FY2025 Net Income$8.51B▲ +1672.9% YoY

Trailing 12M (TTM)$9.22Btrailing 4 quarters sum

Net Profit Margin28.9%$8.51B ÷ $29.44B

YoY Change+1672.9%—

5-Year CAGR+133.3%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · GILD net income history · GILD profit margin

Annual net income data

GILD · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$8.51B▲ +1672.9%28.9%$29.44B

FY2024$480.0M▼ 91.5%1.7%$28.75B

FY2023$5.67B▲ +23.4%20.9%$27.12B

FY2022$4.59B▼ 26.2%16.8%$27.28B

FY2021$6.22B▲ +4961.0%22.8%$27.30B

Net income vs peers (Healthcare)

GILD vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Gilead Sciences, Inc.YOU

GILD

$8.51B+1672.9%28.9%

32%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Gilead Sciences, Inc. (GILD) reported net income of $8.51B for FY2025 (fiscal year ending 2025-12-31), up 1672.9% year-over-year. The net profit margin was 28.9% — meaning the company kept $0.29 of every dollar of revenue as profit.

Based on available data, Gilead Sciences, Inc. has been profitable since at least 2011. Net income reached a peak of $18.11B in FY2015. Data available for 15 fiscal years.

Gilead Sciences, Inc.'s net profit margin was 28.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Gilead Sciences, Inc. net worth" — the company's market capitalization is a separate figure from GILD net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

GILD net income · 5 questions

Gilead Sciences, Inc. is profitable. The company reported net income of $8.51B for FY2025, a net profit margin of 28.9%. Net income was up 1672.9% year-over-year. Based on available data, Gilead Sciences, Inc. has been profitable since at least 2011.

is GILD profitabledoes GILD make a profitGILD profitabilityGILD profitable company

▸ Source: FMP /income-statement · GAAP · Gilead Sciences, Inc. · Gilead Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026